{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:30:12Z","timestamp":1783643412679,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CMI 2108881"],"award-info":[{"award-number":["CMI 2108881"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK069629"],"award-info":[{"award-number":["R01 DK069629"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jchromb.2022.123500","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T14:23:52Z","timestamp":1665671032000},"page":"123500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Analysis of the binding of warfarin to glyoxal- and methylglyoxal-modified human serum albumin by ultrafast affinity extraction"],"prefix":"10.1016","volume":"1211","author":[{"given":"Sazia","family":"Iftekhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumen","family":"Poddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2022.123500_b0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1248\/bpb.25.695","article-title":"Practical aspects of the ligand-binding and enzymatic properties of human serum albumin","volume":"25","author":"Krach-Hansen","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jchromb.2022.123500_b0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.jchromb.2022.123500_b0015","series-title":"Advances in Protein Chemistry and Structural Biology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apcsb.2015.09.007","article-title":"High-performance affinity chromatography: applications in drug-protein binding studies and personalized medicine","author":"Li","year":"2016"},{"key":"10.1016\/j.jchromb.2022.123500_b0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cca.2013.07.013","article-title":"Review: Glycation of human serum albumin","volume":"425","author":"Anguizola","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jchromb.2022.123500_b0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1067\/mem.2001.114314","article-title":"Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment","volume":"38","author":"Harrigan","year":"2001","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.jchromb.2022.123500_b0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/revac-2013-0029","article-title":"Studies of drug interactions with glycated human serum albumin by high-performance affinity chromatography","volume":"33","author":"Matsuda","year":"2014","journal-title":"Rev. Anal. Chem."},{"key":"10.1016\/j.jchromb.2022.123500_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3640001","article-title":"Assay of advanced glycation end products (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N- and N\u03b5-(1-carboxyethyl)lysine-modified albumin","volume":"364","author":"Ahmed","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.jchromb.2022.123500_b0040","first-page":"1","article-title":"Advanced glycation end products and diabetic complications, Korean","volume":"18","author":"Singh","year":"2014","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.jchromb.2022.123500_b0045","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1177\/193229680800200620","article-title":"A review of glycated albumin as an intermediate glycation index for controlling diabetes","volume":"2","author":"Vernon Roohk","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.jchromb.2022.123500_b0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/DMDI.2008.23.1-2.125","article-title":"Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems - role in ageing and disease","volume":"23","author":"Thornalley","year":"2008","journal-title":"Drug Metab. Drug Interact."},{"key":"10.1016\/j.jchromb.2022.123500_b0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0009-2797(97)00157-9","article-title":"Glutathione-dependent detoxification of \u03b1-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors","volume":"111\u2013112","author":"Thornalley","year":"1998","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jchromb.2022.123500_b0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.chroma.2015.09.023","article-title":"Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: studies with normal and glycated human serum albumin","volume":"1416","author":"Matsuda","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2022.123500_b0065","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1021\/ac303734c","article-title":"Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin","volume":"85","author":"Anguizola","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2022.123500_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461683","article-title":"Studies of binding by sulfonylureas with glyoxal- and methylglyoxal-modified albumin by immunoextraction using affinity microcolumns","volume":"1638","author":"Rodriguez","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2022.123500_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114097","article-title":"High-performance affinity chromatographic studies of repaglinide and nateglinide interactions with normal and glyoxal- or methylglyoxal-modified human albumin serum","volume":"201","author":"Ovbude","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123500_b0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chroma.2014.10.092","article-title":"Analysis of free drug fractions by ultrafast affinity extraction: interactions of sulfonylurea drugs with normal or glycated human serum albumin","volume":"1371","author":"Zheng","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2022.123500_b0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jchromb.2018.10.015","article-title":"Binding studies based on ultrafast affinity extraction and single- or two-column systems: interactions of second- and third-generation sulfonylurea drugs with normal or glycated human serum albumin","volume":"1102\u20131103","author":"Yang","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2022.123500_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.123047","article-title":"Evaluation of microcolumn stability in ultrafast affinity extraction for binding and rate studies","volume":"1187","author":"Iftekhar","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2022.123500_b0095","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1021\/acs.analchem.5b03007","article-title":"Analysis of hormone-protein binding in solution by ultrafast affinity extraction: interactions of testosterone with human serum albumin and sex hormone binding globulin","volume":"87","author":"Zheng","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2022.123500_b0100","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1021\/ac501031y","article-title":"Determination of rate constants and equilibrium constants for solution-phase drug-protein interactions by ultrafast affinity extraction","volume":"86","author":"Zheng","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2022.123500_b0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00216-015-9082-7","article-title":"Analysis of free drug fractions in human serum by ultrafast affinity extraction and two-dimensional affinity chromatography","volume":"408","author":"Zheng","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2022.123500_b0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.chroma.2015.12.084","article-title":"Analysis of free drug fractions in serum by ultrafast affinity extraction and two-dimensional affinity chromatography using \u03b11-acid glycoprotein microcolumns","volume":"1432","author":"Bi","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2022.123500_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462240","article-title":"Characterization of drug binding with alpha1-acid glycoprotein in clinical samples using ultrafast affinity extraction","volume":"1649","author":"Beeram","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2022.123500_b0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.chroma.2017.03.056","article-title":"Chromatographic studies of drug interactions with alpha1-acid glycoprotein by ultrafast affinity extraction and peak profiling","volume":"1497","author":"Beeram","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2022.123500_b0125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2018.02.021","article-title":"Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction","volume":"146","author":"Beeram","year":"2018","journal-title":"Methods"},{"key":"10.1016\/j.jchromb.2022.123500_b0130","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jpba.2006.02.012","article-title":"Stability of warfarin solutions for drug-protein binding measurements: spectroscopic and chromatographic studies","volume":"41","author":"Moser","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123500_b0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jchromb.2018.09.001","article-title":"Chromatographic studies of chlorpropamide interactions with normal and glycated human serum albumin based on affinity microcolumns","volume":"1097\u20131098","author":"Tao","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2022.123500_b0140","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpba.2019.01.025","article-title":"Characterization of tolazamide binding with glycated and normal human serum albumin by using high-performance affinity chromatography","volume":"166","author":"Tao","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123500_b0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-2952(00)00287-2","article-title":"Kinetics and mechanism of the reaction of aminoguanidine with the \u03b1-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions","volume":"60","author":"Thornalley","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jchromb.2022.123500_b0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ab.2019.02.014","article-title":"Determination of glyoxal and methylglyoxal in serum by UHPLC coupled with fluorescence detection","volume":"573","author":"Dhananjayan","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jchromb.2022.123500_b0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.abb.2005.10.019","article-title":"The effect of non-enzymatic glycation on the unfolding of human serum albumin","volume":"444","author":"Mendez","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jchromb.2022.123500_b0160","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nm.2121","article-title":"A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response","volume":"16","author":"Winnay","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jchromb.2022.123500_b0165","series-title":"Handbook of Affinity Chromatography","first-page":"36","article-title":"Immobilization methods for affinity chromatography","author":"Kim","year":"2006"},{"key":"10.1016\/j.jchromb.2022.123500_b0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1172\/JCI105968","article-title":"Interaction of the anticoagulant drug warfarin and its metabolites with human plasma albumin","volume":"48","author":"O\u2019Reilly","year":"1969","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jchromb.2022.123500_b0175","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/ac00093a043","article-title":"Chiral separation mechanisms in protein-based HPLC columns. 1. Thermodynamic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin","volume":"66","author":"Loun","year":"1994","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2022.123500_b0180","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jpba.2010.04.035","article-title":"The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan","volume":"53","author":"Joseph","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123500_b0185","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1007\/s00216-013-6981-3","article-title":"Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin","volume":"405","author":"Jackson","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2022.123500_b0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cca.2010.10.018","article-title":"Comparison of modification sites formed on human serum albumin at various stages of glycation","volume":"412","author":"Barnaby","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jchromb.2022.123500_b0195","unstructured":"S.T. Ovbude, Analysis of the metabolic effects of diabetes on the function and structure of modified human serum albumin, Ph.D. dissertation, University of Nebraska-Lincoln, Lincoln, 2022."},{"key":"10.1016\/j.jchromb.2022.123500_b0200","series-title":"Handbook of Affinity Chromatography","first-page":"595","article-title":"Quantitative affinity chromatography: practical aspects","author":"Hage","year":"2006"},{"key":"10.1016\/j.jchromb.2022.123500_b0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2018.01.020","article-title":"Analysis of solute-protein interactions and solute-solute competition by zonal elution affinity chromatography","volume":"146","author":"Tao","year":"2018","journal-title":"Methods"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222004056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222004056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:08:46Z","timestamp":1761606526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023222004056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":41,"alternative-id":["S1570023222004056"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123500","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the binding of warfarin to glyoxal- and methylglyoxal-modified human serum albumin by ultrafast affinity extraction","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123500"}}